Search Results for "vol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for vol. Results 701 to 710 of 1447 total matches.
Drugs for Breast Cancer
Treatment Guidelines from The Medical Letter • Jan 01, 2005 (Issue 29)
Vol. 3 (Issue 29) January 2005
Published by The Medical Letter, Inc.
1000 Main Street ...
In addition to surgery and radiation therapy, a variety of drugs are used both singly and in combination to treat breast cancer. This article summarizes the principles of adjuvant therapy and treatment for metastatic disease. A summary of individual drugs and their adverse effects begins on page 3.
Menostar - A Low-Dose Estrogen Patch for Osteoporosis
The Medical Letter on Drugs and Therapeutics • Aug 30, 2004 (Issue 1190)
Publication
Vol. 46 (Issue 1190)
August 30, 2004
EDITOR: Mark Abramowicz, M.D. DEPUTY EDITOR: Gianna ...
The FDA has approved a new low-dose estrogen patch (Menostar - Berlex) for prevention of osteoporosis in postmenopausal women. Unlike other estrogen patches, it is not approved for treatment of hot flashes or other menopausal symptoms. Promotional material from the manufacturer suggests that this low dose of estrogen could prevent osteoporosis without some of the adverse effects of higher doses.
Tinidazole (Tindamax) - A New Anti-Protozoal Drug
The Medical Letter on Drugs and Therapeutics • Aug 30, 2004 (Issue 1190)
by The Medical Letter, Inc. 1000 Main Street, New Rochelle, NY 10801 A Nonprofit Publication
Vol. 46 (Issue ...
Tinidazole (Tindamax - Presutti Labs), an oral antiprotozoal drug similar to metronidazole (Flagyl, and others), has been approved by the FDA for treatment of trichomoniasis in adults and for treatment of giardiasis, intestinal amebiasis and amebic liver abcess in adults and children more than 3 years old. Tinidazole has been widely used outside of the US for decades under the trade name Fasigyn (Pfizer).
Atomoxetine (Strattera) Revisited
The Medical Letter on Drugs and Therapeutics • Aug 16, 2004 (Issue 1189)
Publication
Vol. 46 (Issue 1189)
August 16, 2004
EDITOR: Mark Abramowicz, M.D. DEPUTY EDITOR: Gianna ...
Atomoxetine (Strattera - Lilly), a nonstimulant drug that is not a controlled substance, was approved by the FDA in early 2003 for the treatment of attention deficit hyperactivity disorder (ADHD). At that time, The Medical Letter concluded that it was unclear whether atomoxetine was as effective as stimulants such as methylphenidate (Concerta, and others) (Medical Letter 2003; 45:11). Since then, the drug has been heavily advertised directly to the public for use in both children and...
Telithromycin (Ketek) for Respiratory Infections
The Medical Letter on Drugs and Therapeutics • Aug 16, 2004 (Issue 1189)
Publication
Vol. 46 (Issue 1189)
August 16, 2004
EDITOR: Mark Abramowicz, M.D. DEPUTY EDITOR: Gianna ...
Telithromycin (Ketek - Aventis) has been approved by the FDA for oral treatment of mild to moderate community-acquired pneumonia, acute exacerbations of chronic bronchitis and acute bacterial sinusitis in patients age 18 and older. The drug is the first in a new class of antibiotics, the ketolides, derived from the macrolide erythromycin. Telithromycin has been marketed in Europe since 2001.
Do NSAIDs Interfere with the Cardioprotective Effects of Aspirin?
The Medical Letter on Drugs and Therapeutics • Aug 02, 2004 (Issue 1188)
Vol. 46 (Issue 1188)
August 2, 2004
EDITOR: Mark Abramowicz, M.D. DEPUTY EDITOR: Gianna Zuccotti ...
Low-dose aspirin is widely used as an antiplatelet drug to reduce the risk of cardiovascular disease (Medical Letter 2000; 42:18). Recent reports suggest that the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (Motrin, and others) may decrease the efficacy of aspirin for this indication. The manufacturer of Tylenol is capitalizing on these reports by advertising that aspirin-taking patients who need pain relief should use acetaminophen instead of ibuprofen.
Methamphetamine Abuse
The Medical Letter on Drugs and Therapeutics • Aug 02, 2004 (Issue 1188)
10801 A Nonprofit Publication
Vol. 46 (Issue 1188)
August 2, 2004
EDITOR: Mark Abramowicz, M.D ...
Methamphetamine, a highly addictive synthetic sympathomimetic, has again become important as a drug of abuse in the US. Its resurgence has been associated with unsafe sexual practices that have resulted in an increase in HIV transmission, particularly among men who have sex with men (SJ Semple et al, J Subst Abuse Treat 2002; 22:149; A Urbina and K Jones, Clin Infect Dis 2004; 38:890).
Trospium (Sanctura): Another Anticholinergic for Overactive Bladder
The Medical Letter on Drugs and Therapeutics • Aug 02, 2004 (Issue 1188)
, with a terminal half-life of 18 hours.
63
Vol. 46 (Issue 1188)
August 2, 2004
Federal copyright law prohibits ...
Trospium chloride (Sanctura - Indevus/Odyssey) has been approved by the FDA for treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and urinary frequency. It has been available in Europe for many years.
Performance-Enhancing Drugs
The Medical Letter on Drugs and Therapeutics • Jul 19, 2004 (Issue 1187)
Publication
Vol. 46 (Issue 1187)
July 19, 2004
EDITOR: Mark Abramowicz, M.D. DEPUTY EDITOR: Gianna Zuccotti ...
With the 2004 Olympics only weeks away, performance-enhancing drugs will once again be receiving a great deal of attention. The US Anti-Doping Agency has published a list of drugs banned in Olympic sports (www.usantidoping.org) that includes, at least for some sports, all but 2 of the drugs reviewed here.
Catheter Ablation for Atrial Fibrillation
The Medical Letter on Drugs and Therapeutics • Jul 19, 2004 (Issue 1187)
Publication
Vol. 46 (Issue 1187)
July 19, 2004
EDITOR: Mark Abramowicz, M.D. DEPUTY EDITOR: Gianna Zuccotti ...
Advertisements are appearing in medical journals for continuing medical education courses on catheter ablation of atrial fibrillation. Is a cure at hand for this common disorder?